Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Ferrosoferric Oxide × Sarcoma × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 CNS 3 Sarcoma 1 Head & Neck 1 Endocrine 1

Conditions

Interventions

Radiotherapy 11 Magnetic Resonance Spectroscopy 11 Ifosfamide 11 Doxorubicin 11 Blood Specimen Collection 11 fludarabine phosphate 8 Surveys and Questionnaires 8 Methotrexate 8 Cyclophosphamide 8 Surgical Procedures, Operative 7 Radiosurgery 7 Cyclosporine 7 Proton Therapy 6 Peripheral Blood Stem Cell Transplantation 6 Mycophenolic Acid 6 Standard of Care 5 Melphalan 5 Filgrastim 5 Busulfan 5 Biopsy 5 Whole-Body Irradiation 4 Vincristine 4 Temozolomide 4 Radiation Dose Hypofractionation 4 Mesna 4 Etoposide 4 Endoscopic Mucosal Resection 4 Early Intervention, Educational 4 Carboplatin 4 Antilymphocyte Serum 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01663090 2020-10-19

Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas

Dana-Farber Cancer Institute

Phase NA Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡